Entoptic foveal avascular zone measurement and diabetic retinopathy

Optometry and Vision Science

Volumn 76, Issue 12, 1999, Pages 826-831

  Hilmantel, Gene ^a   Applegate, Raymond A ^a   Van Heuven, W A J ^a   Stowers, Steven P ^a   Bradley, Arthur ^b   Lee, Bailey L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Diabetic retinopathy; Entoptic phenomena; Foveal avascular zone (FAZ); Retinal vasculature

Indexed keywords

DISEASES; NONINVASIVE MEDICAL PROCEDURES; VISION; VISUALIZATION;

ENTOPTIC PHENOMENA; FOVEAL AVASCULAR ZONE;

OPHTHALMOLOGY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA FOVEA; RETINA IMAGE;

EID: 0032794014     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006324-199912000-00017     Document Type: Article

References (38)

1. Nettleship E. Note on retinal blood vessels of the yellow spot. Roy Lond Ophthalmol Hosp Rep 1875;8:269.
2. Weale RA. Why does the human retina possess a fovea? Nature 1966; 212:255-6.
3. Applegate RA, Bradley A, van Heuven WA. Entoptic visualization of the retinal vasculature near fixation. Invest Ophthalmol Vis Sci 1990; 31:2088-98.
4. Kuwabara T, Carroll JM, Cogan DG. Retinal vascular patterns. Arch Ophthalmol 1961;65:708-16.
5. Kuwabara T, Cogan DG. Studies of retinal vascular patterns. Arch Ophthalmol 1960;64:904-11.
6. Bligard E, de Venecia G, Wallow I, Bresnick GH, Syrjala S. Aging changes of the parafoveolar vasculature: a trypsin digest study. Invest Ophthalmol Vis Sci 1982;22(suppl):8.
7. Snodderly DM, Weinhaus RS. Retinal vasculature of the fovea of the squirrel monkey, Saimiri sciureus: three-dimensional architecture, visual screening, and relationships to the neuronal layers. J Comp Neurol 1990;297:145-63.
8. Snodderly DM, Weinhaus RS, Choi JC. Neural-vascular relationships in central retina of macaque monkeys (Macaca fascicularis). J Neurosci 1992;12:1169-93.
9. Henkind P. Symposium on glaucoma: joint meeting with the National Society for the Prevention of Blindness. New observations on the radial peripapillary capillaries. Invest Ophthalmol 1967;6:103-8.
10. Heimann K. Choroidal vascular pattern in the macular region. Mod Probl Ophthalmol 1974;12:229-33.
11. Shimizu K, Ujiie K. Structure of Ocular Vessels. New York: Igaku-Shoin; 1978.
12. Laatinainen L, Larinkari J. Capillary-free area of the fovea with advancing age. Invest Ophthalmol Vis Sci 1977;16:1154-7.
13. Ibayashi H, Nishimura M, Yamana T. Avascular zone in the macula in cicatricial retinopathy of prematurity. Am J Ophthalmol 1985;99: 235-9.
14. Bresnick GH, Condit R, Syrjala S, Palta M, Groo A, Korth K. Abnormalities of the foveal avascular zone in diabetic retinopathy. Arch Ophthalmol 1984;102:1286-93.
15. Stevens TS, Busse B, Lee CB, Woolf MB, Galinos SO, Goldberg MF. Sickling hemoglobinopathies; macular and perimacular vascular abnormalities. Arch Ophthalmol 1974;92:455-63.
16. Friberg TR, Gragoudas ES, Regan CD. Talc emboli and macular ischemia in intravenous drug abuse. Arch Ophthalmol 1979;97: 1089-91.
17. Gass JD. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. II. Retinal vein obstruction. Arch Ophthalmol 1968;80:550-68.
18. Riva CE, Petrig B. Blue field entoptic phenomenon and blood velocity in the retinal capillaries. J Opt Soc Am 1980;70:1234-8.
19. Yap M, Gilchrist J, Weatherill J. Psychophysical measurement of the foveal avascular zone. Ophthalmic Physiol Opt 1987;7:405-10.
20. Purkinje JE. Beobachtungen und Versuche zur Physiologie der Sinne. Prague: J. Calve; 1819.
21. Bradley A, Applegate RA, van Heuven WA, Nair P. FAZ enlargement and visual acuity in diabetic retinopathy. Invest Ophthalmol Vis Sci 1994;35(Suppl):1395.
22. Nunez R, Applegate RA, Bradley A, Hendricks JJ. Clinical version of the vascular entoptoscope. Vision Science and Its Applications. 1996 Technical Digest Series, Vol. 1. Washington (DC): Optical Society of America; 1996. p. 160-63.
23. Zeffren BS, Applegate RA, Bradley A, van Heuven WA. Retinal fixation point location in the foveal avascular zone. Invest Ophthalmol Vis Sci 1990;31:2099-105.
24. Bradley A, Applegate RA, Zeffren BS, van Heuven WA. Psychophysical measurement of the size and shape of the human foveal avascular zone. Ophthalmic Physiol Opt 1992;12:18-23.
25. Applegate RA, Bradley A, van Heuven WA, Lee BL, Garcia CA. Entoptic evaluation of diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:783-91.
26. Bradley A, Zhang H, Applegate RA, Thibos L, Elsner A. Entoptic image quality of the retinal vasculature. Vision Res 1998;38: 2685-96.
27. Yeung J, Crock G, Cairns J, Heinze J, Troski S, Billson F. Macularfoveal capillaries in human retina. Aust J Ophthalmol 1973;1:17-23.
28. Weale RA. Why is there a fovea in the human retina? Proc R Soc Med 1969;62:573-4.
29. Kluxen G, Wilden E. An entoptic test in diabetic patients. Diabetes Care 1987;10:800-1.
30. Kohner EM. Retinal ischemia. In: Ryan SJ, editor. Retina, Vol. 2. Schachat AP, Murphy RP, editors. Medical Retina. St. Louis: C. V. Mosby; 1994. p. 89-97.
31. Mansour AM, Schachat A, Bodiford G, Haymond R. Foveal avascular zone in diabetes mellitus. Retina 1993;13:125-8.
32. Arend O, Wolf S, Jung F, Bertram B, Postgens H, Toonen H, Reim M. Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol 1991;75:514-8.
33. Emsley HH. Visual Optics. Vol. 1. London: Hatton Press; 1936. p. 344.
34. The Diabetic Retinopathy Study Research Group. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981;21:210-26.
35. Early Treatment of Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. Report number 10. Ophthalmology 1991;98:786-806.
36. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Amino-guanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 1991;88:11555-8.
37. Jackson WE, Holmes DL, Garg SK, Harris S, Chase HP. Angiotensin-converting enzyme inhibitor therapy and diabetic retinopathy. Ann Ophthalmol 1992;24:99-103.
38. Robison WG, Jr., Laver NM, Jacot JL, Chandler ML, York BM, Glover JP. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats. Invest Ophthalmol Vis Sci 1997;38: 1066-73.